EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer

Nur Aqlili Riana Alias iD, Winfrey Pui Yee Hoo, Pui Yan Siak, Siti Sarah Othman iD, Noorjahan Banu Mohammed Alitheen, Lionel Lian Aun In iD, Raha Abdul Rahim, Adelene Ai-Lian Song iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24108928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nur Aqlili Riana Alias und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia. Hauptthemen laut MEDLINE: Lactococcus lactis, Vaccines, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia, Research Excellence and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is often caused by mutations in the KRAS oncogene, making KRAS neoantigens a promising vaccine candidate for immunotherapy. Secreting KRAS antigens using live Generally Recognized as Safe (GRAS) vaccine delivery hosts such as Lactococcus lactis is deemed to be an effective strategy in inducing specific desired responses. Recently, through the engineering of a novel signal peptide SPK1 from Pediococcus pentosaceus, an optimized secretion system was developed in the L. lactis NZ9000 host. In this study, the potential of the L. lactis NZ9000 as a vaccine delivery host for the production of two KRAS oncopeptides (mutant 68V-DT and wild-type KRAS) through the use of the signal peptide SPK1 and its mutated derivative (SPKM19) was investigated. The expression and secretion efficiency analyses of KRAS peptides from L. lactis were performed in vitro and in vivo in BALB/c mice. Contradictory to our previous study using the reporter staphylococcal nuclease (NUC), the yield of secreted KRAS antigens mediated by the target mutant signal peptide SPKM19 was significantly lower (by ~1.3-folds) compared to the wild-type SPK1. Consistently, a superior elevation of IgA response against KRAS aided by SPK1 rather than mutant SPKM19 was observed. Despite the lower specific IgA response for SPKM19, a positive IgA immune response from mice intestinal washes was successfully triggered following immunization. Size and secondary conformation of the mature proteins are suggested to be the contributing factors for these discrepancies. This study proves the potential of L. lactis NZ9000 as a host for oral vaccine delivery due to its ability to evoke the desired mucosal immune response in the gastrointestinal tract of mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactococcus lactisVaccinesColorectal NeoplasmsAnimalsMiceProto-Oncogene Proteins p21(ras)AntigensImmunity, MucosalProtein Sorting SignalsImmunoglobulin A

Stichwörter der Autor:innen

Lactococcus lactisSPK1colorectal cancerimmunotherapymucosal vaccine deliverymutant KRAS antigensecretionsignal peptide

Substanzen

Proto-Oncogene Proteins p21(ras)AntigensVaccinesProtein Sorting SignalsImmunoglobulin A

Autor:innen und Institutionen

  • Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.
  • Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
  • Faculty of Medicine and Health Sciences, UCSI University, Bandar Springhill, Port Dickson 71010, Malaysia.
  • UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Malaysia.
  • Department of Biotechnology, Faculty of Applied Sciences, UCSI University Kuala Lumpur, Cheras 56000, Malaysia.
  • National Institutes of Biotechnology Malaysia, Argo-Biotechnology Institute Malaysia Complex, Serdang 43400, Malaysia.

ORCID-Profile: Nur Aqlili Riana Alias, Siti Sarah Othman, Lionel Lian Aun In, Adelene Ai-Lian Song

Förderung

  • Fundamental Research Grant Scheme of the Ministry of Higher Education, Malaysia
  • Research Excellence and Innovation

Zitieren

APA

Alias, N. A. R., Hoo, W. P. Y., Siak, P. Y., Othman, S. S., Mohammed Alitheen, N. B., In, L. L. A., Abdul Rahim, R., & Song, A. A. (2023). Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108928

Vancouver

Alias NAR, Hoo WPY, Siak PY, Othman SS, Mohammed Alitheen NB, In LLA, et al. Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108928

BibTeX
@article{Alias2023,
  author = {Alias, Nur Aqlili Riana and Hoo, Winfrey Pui Yee and Siak, Pui Yan and Othman, Siti Sarah and Mohammed Alitheen, Noorjahan Banu and In, Lionel Lian Aun and Abdul Rahim, Raha and Song, Adelene Ai-Lian},
  title = {Effect of Secretion Efficiency of Mutant KRAS Neoantigen by Lactococcus lactis on the Immune Response of a Mucosal Vaccine Delivery Vehicle Targeting Colorectal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24108928}
}
Kostenlos starten →